believe study of bimagrumab + semaglutide A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass β suggesting a promising approach for π¬ The BELIEVE Phase 2b
Pay in 4 interest-free payments of $6.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18











00213-0/asset/44e20ecd-2857-445f-a9fe-749ba0b1cd65/main.assets/gr2_lrg.jpg)

![PDF] A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes](https://ai2-s2-public.s3.amazonaws.com/figures/2017-08-08/7c7543416a247a5a34e98769da2d20a023a4651c/6-Figure2-1.png)









